Bioorganic Chemistry Department, Faculty of Pharmacy, Al-Quds University, P.O. Box 20002, Jerusalem, Palestine; Department of Science, University of Basilicata, Via dell'Ateneo Lucano 10, 85100, Potenza, Italy.
Chem Biol Drug Des. 2013 Dec;82(6):643-68. doi: 10.1111/cbdd.12224. Epub 2013 Oct 25.
This review provides the reader a concise overview of the majority of prodrug approaches with the emphasis on the modern approaches to prodrug design. The chemical approach catalyzed by metabolic enzymes which is considered as widely used among all other approaches to minimize the undesirable drug physicochemical properties is discussed. Part of this review will shed light on the use of molecular orbital methods such as DFT, semiempirical and ab initio for the design of novel prodrugs. This novel prodrug approach implies prodrug design based on enzyme models that were utilized for mimicking enzyme catalysis. The computational approach exploited for the prodrug design involves molecular orbital and molecular mechanics (DFT, ab initio, and MM2) calculations and correlations between experimental and calculated values of intramolecular processes that were experimentally studied to assign the factors determining the reaction rates in certain processes for better understanding on how enzymes might exert their extraordinary catalysis.
这篇综述为读者提供了对大多数前药方法的简要概述,重点介绍了现代前药设计方法。讨论了代谢酶催化的化学方法,该方法被认为是所有其他最小化不良药物物理化学性质的方法中最广泛使用的方法。本综述的一部分将介绍使用分子轨道方法(如 DFT、半经验和从头算)设计新型前药。这种新型前药方法意味着基于酶模型的前药设计,这些模型用于模拟酶催化。用于前药设计的计算方法涉及分子轨道和分子力学(DFT、从头算和 MM2)计算以及实验和计算的分子内过程值之间的相关性,这些过程值是经过实验研究的,以确定决定某些过程中反应速率的因素,以便更好地了解酶如何发挥其非凡的催化作用。